Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01924364 · ClinicalTrials.gov registry record · NA
Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using TGI Device
A NA study, sponsored by J. Peter Rubin, MD.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01924364 is a NA study that has completed, run by J. Peter Rubin, MD. The registered enrollment target is 7 participants.
The verdict
NCT01924364, a NA study, has completed, sponsored by J. Peter Rubin, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The overall purpose of this research is to evaluate the physical changes that occur over time after fat grafting for craniofacial trauma. This protocol is similar to an existing study (IRB# PRO0906101) presently conducted at the University of Pittsburgh by the same research team which utilizes fat grafts. The preparation of the fat graft material in each clinical trial is processed differently evaluating the effects of graft resorption after treatment.
Interventions
- DEVICE Tissue Genesis Cell Isolation System™ (TGI CIS)
- PROCEDURE Standard of care fat grafting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-06-30 |
| Est. Completion | 2016-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01924364
The ClinicalTrials.gov registry entry for NCT01924364 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is J. Peter Rubin, MD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tissue Genesis Cell Isolation System™ (TGI CIS) is the first listed.
NCT01924364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01924364 about?
NCT01924364 is a clinical study titled "Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using TGI Device". The overall purpose of this research is to evaluate the physical changes that occur over time after fat grafting for craniofacial trauma. This protocol is similar to an existing study (IRB# PRO0906101) presently conducted at the University of Pittsburgh by the same research team which utilizes fat g...
What is the current status of trial NCT01924364?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2012-06-30. Estimated completion is 2016-09-28.
What interventions are being tested in trial NCT01924364?
The interventions under investigation include: Tissue Genesis Cell Isolation System™ (TGI CIS) (DEVICE), Standard of care fat grafting (PROCEDURE).
Who is sponsoring clinical trial NCT01924364?
This trial is sponsored by J. Peter Rubin, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.